| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |